Standard InChI: InChI=1S/C40H50N8O10/c1-23(44-37(55)29(41)18-25-9-13-27(50)14-10-25)36(54)46-30(19-24-6-3-2-4-7-24)38(56)43-21-34(52)45-31(20-26-11-15-28(51)16-12-26)40(58)48-17-5-8-33(48)39(57)47-32(22-49)35(42)53/h2-4,6-7,9-16,23,29-33,49-51H,5,8,17-22,41H2,1H3,(H2,42,53)(H,43,56)(H,44,55)(H,45,52)(H,46,54)(H,47,57)/t23-,29-,30-,31-,32-,33-/m0/s1
2.Turnaturi R, Aricò G, Ronsisvalle G, Parenti C, Pasquinucci L.. (2016) Multitarget opioid ligands in pain relief: New players in an old game., 108 [PMID:26656913][10.1016/j.ejmech.2015.11.028]
3.Adamska A, Kluczyk A, Cerlesi MC, Calo G, Janecka A, Borics A.. (2016) Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogs., 24 (7):[PMID:26944625][10.1016/j.bmc.2016.02.034]
4.Pacifico S, Albanese V, Illuminati D, Marzola E, Fabbri M, Ferrari F, Holanda VAD, Sturaro C, Malfacini D, Ruzza C, Trapella C, Preti D, Lo Cascio E, Arcovito A, Della Longa S, Marangoni M, Fattori D, Nassini R, Calò G, Guerrini R.. (2021) Novel Mixed NOP/Opioid Receptor Peptide Agonists., 64 (10.0):[PMID:33998786][10.1021/acs.jmedchem.0c02062]
5.Smith MT, Kong D, Kuo A, Imam MZ, Williams CM.. (2022) Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources., 65 (3.0):[PMID:34995453][10.1021/acs.jmedchem.0c01915]